About Myeloma Canada Research Network
Redefining and Revolutionizing Research
The mission of the Myeloma Canada Research Network is to:
- Conduct innovative Phase I and II clinical and translational research in a collaborative manner to improve patient outcomes in multiple myeloma
- Publish evidence-based and peer reviewed consensus statements on the diagnosis and treatment of myeloma
- Develop a nationwide myeloma patient database
The MCRN is comprised of 24 centres in 9 provinces accross Canada
As a patient organization, Myeloma Canada promotes its commitment to patient-focused clinical research in collaboration with the Myeloma Canada Research Network (MCRN). The unique network of Canadian world-class myeloma researchers brings Canadian-designed clinical trials to patients, while promoting the sharing of scientific data and expertise amongst its members, to gain access to new therapies in an accelerated manner for Canadian patients, leading to improved overall outcomes.